James B. Hoffman is a notable inventor based in King of Prussia, PA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of oxytocin antagonists. With a total of 2 patents, Hoffman's work is pivotal in addressing critical medical conditions.

Latest Patents

Hoffman's latest patents include innovative compounds aimed at treating various medical issues. One of his inventions is focused on piperazinylcamphorsulfonyl oxytocin antagonists. This invention introduces a series of novel compounds where the camphor ring is substituted by various functional groups. These compounds are designed to be effective in treating preterm labor, dysmenorrhea, and for stopping labor in preparation for cesarean delivery. Another significant patent involves amide-substituted derivatives of spiroindanylcamphorsulfonyl oxytocin. These compounds serve as oxytocin and vasopressin antagonists, useful in treating conditions such as preterm labor, endometriosis, and hypertension. Additionally, pharmaceutical compositions containing these compounds and methods for their preparation are disclosed.

Career Highlights

James B. Hoffman is currently associated with Merck & Co., Inc., a leading pharmaceutical company. His work at Merck has allowed him to focus on groundbreaking research and development in the pharmaceutical sector. Hoffman's contributions have been instrumental in advancing medical treatments that improve patient outcomes.

Collaborations

Hoffman has collaborated with notable colleagues, including Doug W. Hobbs and Mark G. Bock. These collaborations have fostered an environment of innovation and have led to the successful development of new pharmaceutical compounds.

Conclusion

James B. Hoffman is a distinguished inventor whose work in the field of oxytocin antagonists has the potential to transform medical treatments. His patents reflect a commitment to addressing significant health challenges, and his collaborations further enhance the impact of his innovations.